R-CHOP in the treatment of DLBCL: Single institution experience from north India.

被引：0
|
作者：
Vaid, AK [1 ]
Gupta, S [1 ]
Doval, DC [1 ]
Talwar, V [1 ]
Gupta, R [1 ]
Sharma, JB [1 ]
Chaturvedi, AK [1 ]
Prakesh, N [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Delhi, India
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4773.4773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4773
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [1] Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
    Marshall, Shoko
    Nishimura, Noriko
    Inoue, Norihito
    Yamauchi, Hirofumi
    Tsuyama, Naoko
    Takeuchi, Kengo
    Mishima, Yuko
    Yokoyama, Masahiro
    Ogasawara, Toshie
    Mori, Naoki
    Ogawa, Tetsuya
    Sakura, Hiroshi
    Terui, Yasuhito
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 162 - 169
  • [2] Prognostic PET after R-CHOP in DLBCL
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) : 17N - 17N
  • [3] R-CHOP in DLBCL: priming for success Comment
    Hertzberg, Mark
    BLOOD, 2022, 139 (08) : 1121 - 1122
  • [4] Is it time to stop treating subsets of DLBCL with R-CHOP?
    Moskowitz, C
    BLOOD, 2006, 107 (11) : 4197 - 4198
  • [5] Split-Dose R-CHOP for Older Patients with Treatment Naive DLBCL
    Kidwell, Adam
    Furqan, Fateeha
    Aschenbrenner, Emilie
    Longo, Walter
    Devata, Sumana
    Hamadani, Mehdi
    Fenske, Timothy S.
    Shah, Nirav N.
    BLOOD, 2024, 144 : 2374 - 2375
  • [6] TREATMENT OF C-MYC/BCL2 DOUBLE EXPRESSER DLBCL WITH R-CHOP CHEMOIMMUNOTHERAPY: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE
    Ng, T. F.
    Whiteside, A.
    Rose, H.
    Kipp, D.
    Tawfik, B.
    Campbell, P.
    HAEMATOLOGICA, 2016, 101 : 701 - 701
  • [7] Succeeding in Breaking the R-CHOP Ceiling in DLBCL: Learning From Negative Trials
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3519 - +
  • [8] Retrospective Study of Standard R-CHOP Therapy in Localized DLBCL
    Tomita, Naoto
    Takasaki, Hirotaka
    Miyashita, Kazuho
    Fujisawa, Shin
    Ogusa, Eriko
    Matsuura, Shro
    Kishimoto, Kumiko
    Numata, Ayumi
    Fujita, Atsuko
    Ohshima, Rika
    Kuwabara, Hideyuki
    Hagihara, Maki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Koharazawa, Hideyuki
    Yamazaki, Etsuko
    Fujimaki, Katsumichi
    Taguchi, Jun
    Sakai, Rika
    Ishigatsubo, Yoshiaki
    BLOOD, 2012, 120 (21)
  • [9] Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
    Wilson, Wyndham H.
    Wright, George W.
    Huang, Da Wei
    Hodkinson, Brendan
    Balasubramanian, Sriram
    Fan, Yue
    Vermeulen, Jessica
    Shreeve, Martin
    Staudt, Louis M.
    CANCER CELL, 2021, 39 (12) : 1643 - +
  • [10] VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION
    Castellino, A.
    Novo, M.
    Chiappella, A.
    Ciochetto, C.
    Vittone, F.
    Botto, B.
    Cavallo, F.
    Orsucci, L.
    Boccomini, C.
    Evangelista, A.
    Ghione, P.
    Nicolosi, M.
    Santambrogio, E.
    Ciccone, G.
    Novero, D.
    Vitolo, U.
    HAEMATOLOGICA, 2017, 102 : 111 - 111
12345